MiNK Therapeutics Ownership | Who Owns MiNK Therapeutics?

MiNK Therapeutics Ownership Summary

MiNK Therapeutics is owned by 2.14% institutional investors, 74.65% insiders, and 23.21% retail investors. Vanguard group is the largest institutional shareholder, holding 0.68% of INKT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.37% of its assets in MiNK Therapeutics shares.

INKT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	MiNK Therapeutics	2.14%	74.65%	23.21%
Sector	Healthcare Stocks	46.62%	8.13%	45.25%
Industry	Biotech Stocks	44.91%	7.98%	47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	234.18K	0.68%	$222.29K
Longbow finance sa	166.67K	0.48%	$158.20K
Renaissance	127.84K	0.37%	$121.35K
Geode capital management	96.35K	0.28%	$91.47K
Blackrock	87.20K	0.25%	$82.77K
Hightower advisors	50.69K	0.15%	$43.00K
Captrust financial advisors	35.73K	0.10%	$33.91K
State street	25.52K	0.07%	$24.22K
Goldman sachs group	17.56K	0.05%	$16.67K
Millennium management	13.12K	0.04%	$12.45K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Longbow finance sa	166.67K	0.02%	$158.20K
Covestor	1.05K	0.00%	$1.00K
Renaissance	127.84K	0.00%	$121.35K
Tower research capital llc (trc)	8.95K	0.00%	$8.49K
Game plan financial advisors	170.00	0.00%	$161.00
Hightower advisors	50.69K	0.00%	$43.00K
Captrust financial advisors	35.73K	0.00%	$33.91K
Advisor group	1.43K	-	$1.36K
Susquehanna group, llp	-	-	-
Blackrock	87.20K	-	$82.77K

Top Buyers

Holder	Shares	% Assets	Change
Renaissance	127.84K	0.00%	22.61K
Blackrock	87.20K	-	11.05K
Geode capital management	96.35K	-	7.49K
Goldman sachs group	17.56K	-	1.93K
Advisor group	1.43K	-	511.00

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	-	-	-29.83K
Citadel advisors	-	-	-20.81K
Captrust financial advisors	35.73K	0.00%	-18.56K
Millennium management	13.12K	-	-6.98K
Tower research capital llc (trc)	8.95K	0.00%	-2.11K

New Positions

Holder	Shares	% Assets	Change	Value
Clearstead advisors	150.00	-	150.00	$143.00

Sold Out

Holder	Change
Assetmark	-1.00
Harbor investment advisory	-5.00
Lifesteps financial	-28.00
Rhumbline advisers	-48.00
Sittner & nelson	-58.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	26	-13.33%	846,639	-5.78%	2	31.83%	9	-	7	-30.00%
Jun 30, 2024	30	-9.09%	898,529	-4.07%	2	34.90%	9	28.57%	10	-16.67%
Mar 31, 2024	33	-8.33%	936,697	-5.46%	2	33.05%	7	-46.15%	12	20.00%
Dec 31, 2023	36	2.86%	990,803	36.95%	2	64.97%	13	62.50%	10	-41.18%
Sep 30, 2023	35	-16.67%	723,481	-51.03%	2	11.11%	8	-80.49%	17	1600.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	148.23K	0.37%	-
Vanguard Institutional Extnd Mkt Idx Tr	85.95K	0.22%	-
Fidelity Extended Market Index	58.10K	0.15%	2.94K
iShares Micro-Cap ETF	22.49K	0.06%	-
Fidelity Nasdaq Composite Index	19.03K	0.05%	-
Fidelity Series Total Market Index	11.66K	0.03%	-
BlackRock Extended Equity Market K	8.48K	0.02%	-4.00
NT Ext Equity Mkt Idx Fd - L	7.31K	0.02%	-
Northern Trust Extended Eq Market Idx	7.31K	0.02%	-
Fidelity Total Market Index	6.76K	0.02%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 16, 2023	AGENUS INC	-	Buy	$471.56
Oct 12, 2023	AGENUS INC	-	Buy	$3.49K
Oct 13, 2023	AGENUS INC	-	Buy	$21.31K
Oct 04, 2023	AGENUS INC	-	Buy	$16.38K
Aug 29, 2023	AGENUS INC	-	Buy	$45.02K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	4	-
2023 Q3	3	-

INKT Ownership FAQ

Who Owns MiNK Therapeutics?

MiNK Therapeutics shareholders are primarily institutional investors at 2.14%, followed by 74.65% insiders and 23.21% retail investors. The average institutional ownership in MiNK Therapeutics's industry, Biotech Stocks , is 44.91%, which MiNK Therapeutics falls below.

Who owns the most shares of MiNK Therapeutics?

MiNK Therapeutics’s largest shareholders are Vanguard group (234.18K shares, 0.68%), Longbow finance sa (166.67K shares, 0.48%), and Renaissance (127.84K shares, 0.37%). Together, they hold 1.53% of MiNK Therapeutics’s total shares outstanding.

Does Blackrock own MiNK Therapeutics?

Yes, BlackRock owns 0.25% of MiNK Therapeutics, totaling 87.2K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 82.77K$. In the last quarter, BlackRock increased its holdings by 11.05K shares, a 14.51% change.

Who is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested?

Longbow finance sa is MiNK Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.02% of its assets in 166.67K MiNK Therapeutics shares, valued at 158.2K$.

Who is the top mutual fund holder of MiNK Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of MiNK Therapeutics shares, with 0.37% of its total shares outstanding invested in 148.23K MiNK Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools